A Randomized Trial of Lipid Metabolism Modulation with Fenofibrate for Acute Coronavirus Disease 2019
Conclusion Among patients with COVID-19, fenofibrate has no significant effect on various clinically relevant outcomes.PMID:35982675 | PMC:PMC9387540 | DOI:10.21203/rs.3.rs-1933913/v1
Source: Cell Research - Category: Cytology Authors: Julio Chirinos Patricio Lopez-Jaramillo Evangelos Giamarellos-Bourboulis Gonzalo D ávila-Del-Carpio Abdul Bizri Jaime Andrade-Villanueva Oday Salman Carlos Cure-Cure Nelson Rosado-Santander Mario Cornejo Giraldo Luz Gonz ález-Hernández Rima Moghnieh Ra Source Type: research
More News: Coronavirus | COVID-19 | Cytology | Diabetes | Diabetes Mellitus | Endocrinology | Fenofibrate | Nanotechnology | SARS | Tricor | Trilipix